Strategic Partnerships Gateway Analytical is an Aptar Pharma company with a track record of collaborations and industry engagement, including past partnerships and participation in major bioscience events. Leverage existing affiliation to approach clients seeking validated analytical partners with pharmaceutical industry credibility.

Regulatory Focus Recent advancements include cGMP-compliant automated ISPS methods, signaling strong alignment with regulatory expectations and quality systems. Target pharmaceutical manufacturers and contract research organizations prioritizing compliant, scalable particle analysis and Raman imaging capabilities.

Market Expansion Active engagement in industry events such as BIO International Convention and PDA Week indicates emphasis on expanding visibility among sterile manufacturing, injectable product safety, and regulatory science audiences. Use event follow-ups to convert inquiries into pilot projects.

Service Differentiation Specialization in foreign particulate analysis, identification, and materials analysis positions Gateway as a niche provider for challenging quality issues. Position as a high-trust, fast-turnaround partner for complex analytical needs in pharma, medical devices, and materials sectors.

Growth Potential Revenue range and growth history suggest mid-market focus with scalable capabilities. Target mid-to-large pharmaceutical manufacturers and contract labs seeking robust analytical throughput, multi-tech capabilities (including Raman imaging and SEM-EDS), and integration with existing QA workflows.